CSat Investment Advisory’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | $4K | Buy |
121
+53
| +78% | +$1.75K | ﹤0.01% | 503 |
|
|
2020
Q4 | $3K | Sell |
68
-18,497
| -100% | -$816K | ﹤0.01% | 507 |
|
|
2020
Q3 | $646K | Sell |
18,565
-13,350
| -42% | -$465K | 0.06% | 159 |
|
|
2020
Q2 | $990K | Sell |
31,915
-5,315
| -14% | -$165K | 0.12% | 87 |
|
|
2020
Q1 | $1.15M | Buy |
37,230
+11,848
| +47% | +$367K | 0.24% | 52 |
|
|
2019
Q4 | $943K | Buy |
25,382
+6,292
| +33% | +$234K | 0.25% | 78 |
|
|
2019
Q3 | $650K | Buy |
19,090
+10,045
| +111% | +$342K | 0.2% | 87 |
|
|
2019
Q2 | $372K | Buy |
9,045
+9,017
| +32,204% | +$371K | 0.13% | 120 |
|
|
2019
Q1 | $1K | Buy |
28
+4
| +17% | +$143 | ﹤0.01% | 546 |
|
|
2018
Q4 | $1K | Buy |
24
+3
| +14% | +$125 | ﹤0.01% | 543 |
|
|
2018
Q3 | $1K | Sell |
21
-2
| -9% | -$95 | ﹤0.01% | 545 |
|
|
2018
Q2 | $1K | Buy |
+23
| New | +$1K | ﹤0.01% | 550 |
|